Clinical Trials Logo

Intestinal Obstruction clinical trials

View clinical trials related to Intestinal Obstruction.

Filter by:
  • Terminated  
  • Page 1 ·  Next »

NCT ID: NCT04027348 Terminated - Clinical trials for Malignant Bowel Obstruction

Palliative Management of Inoperable Malignant Bowel Obstruction

Start date: June 26, 2019
Phase: Phase 2
Study type: Interventional

To identify the role of palliative medical management of inoperable malignant bowel obstruction (MBO) with Octreotide, Dexamethasone and Metoclopramide given together as triple therapy.

NCT ID: NCT03573921 Terminated - Clinical trials for Small Bowel Obstruction

Gastrografin for Treating Small Bowel Obstruction in Children

Start date: September 1, 2019
Phase: Phase 2/Phase 3
Study type: Interventional

This is a multi-centre clustered open label clinical trial testing the effectiveness of adding Gastrografin to standard non-surgical management of small bowel obstruction. Gastrografin is a radiopaque contract agent that exhibits a mild laxative effective due to its high osmolarity and ability to pull water into the intestines and bowels as a lubricant. Small bowel obstruction is a mechanical or function obstruction that prevents normal bowel function. The standard treatment for small bowel obstruction is non-surgical and includes decompressing the abdomen, fluid resuscitation, nothing by mouth, and time. In some cases if non-surgical management is not effective in resolving the obstruction, surgical intervention is required. Gastrografin in addition to standard non-surgical management has been shown to reduce the rate of surgery, length of hospital stay, and time to resolution in similar clinical scenarios, such as meconium ileus and meconium plug syndrome. However, it has never been tested in children with small bowel obstruction. This study is a clustered open label study, meaning that each participating centre will select the type of treatment they will offer at their centre. The treatment options are either the Gastrografin arm (a single dose of Gastrografin plus non-surgical management) or the Control arm (a single dose of saline solution plus non-surgical management). After each group receives saline or Gastrografin they will continue with the same non-surgical treatment that patients not participating in the trial would receive. Participating in the study does not preclude the need for urgent or emergent surgical intervention and at any point in the study, if the patient requires surgery for their small bowel obstruction they will undergo surgical intervention. The outcomes of this study are the rate of surgical intervention, length of stay, time to first and full feeds, and rate of complications.

NCT ID: NCT02692638 Terminated - Clinical trials for Small Bowel Obstruction

Trial Comparing Early Laparoscopic Enterolysis Versus Nonoperative Management for High-grade SBO

Start date: February 2, 2016
Phase: Phase 2
Study type: Interventional

The goal is to assess the appropriateness of the standard practice of a trial of nonoperative management for high grade small bowel obstruction (currently up to 72 hours based on available literature). The investigator will offer early laparoscopic enterolysis (within 24 hours of admission) as the comparator group.

NCT ID: NCT02365584 Terminated - Clinical trials for Intestinal Obstruction

Quality of Life in Patients With Inoperable Malignant Bowel Obstruction

QoL in IMBO
Start date: January 2015
Phase: Phase 2
Study type: Interventional

The primary objective of the study is to evaluate the impact on quality of life of Lanreotide Autogel 120 mg in combination with standard care, in comparison to the standard care alone, in subjects affected by inoperable malignant bowel obstruction.

NCT ID: NCT02116881 Terminated - Incisional Hernia Clinical Trials

Incisional Hernia and Adhesion-Related Bowel Obstruction

Start date: January 2015
Phase: N/A
Study type: Observational

Despite of technological advances in surgery, incisional hernia and bowel obstruction remain frequent surgical complications. To date, the relationship between these two types of surgery and the occurrence of incisional hernia remains unclear. This is an observational study to evaluate outcomes of incisional hernia with respect to the incision site and adhesion-related bowel obstruction after open and laparoscopic colorectal surgery.

NCT ID: NCT02058290 Terminated - Bowel Obstruction Clinical Trials

A Health Economic Trial in Adult Patients Undergoing Laparoscopic Colectomy

IMPROVE-Lap
Start date: December 2011
Phase: Phase 4
Study type: Interventional

This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospital costs.

NCT ID: NCT01911793 Terminated - Ileus Clinical Trials

Stoma Tube Decompression and Postoperative Ileus After Major Colorectal Surgery

Start date: July 2013
Phase: N/A
Study type: Interventional

Postoperative ileus is common after colorectal surgery, occurring in up to 20% of patients. Stomas are frequently created in conjunction with major colorectal surgery. Obstruction at the level of the stoma is a common cause of bowel obstruction or ileus. This is often manifested by decrease or delay in stoma output and is often attributed to edema at the level of the stoma. Thus, a temporary tube (red robinson catheter) is placed into the stoma at bedside, which often relieves the obstruction until the edema at the level of the stoma resolves and stoma function occurs around the temporary tube. At this time, the tube is removed and the stoma continues to function normally. The purpose of this study is to evaluate whether a stoma tube (red-robinson catheter) placed at the time of stoma creation would reduce the incidence of postoperative ileus in patients undergoing major colorectal surgery with creation of a stoma.

NCT ID: NCT01507233 Terminated - Bowel Obstruction Clinical Trials

A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302

IMPROVE-Open
Start date: May 2012
Phase: Phase 4
Study type: Interventional

This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.

NCT ID: NCT01507220 Terminated - Bowel Obstruction Clinical Trials

A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301

IMPROVE-Open
Start date: March 2012
Phase: Phase 4
Study type: Interventional

This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL therefore possibly reducing total hospitalization costs.

NCT ID: NCT01196494 Terminated - Colorectal Surgery Clinical Trials

Study of Intraoperative Colonic Irrigation Versus Stent Placement in Obstructive Left-Sided Colonic Cancer

Start date: n/a
Phase: N/A
Study type: Interventional

INTRODUCTION: There are several alternatives for one-stage emergency treatment of obstructive left-sided colonic cancer (OLCC): subtotal colectomy, intraoperative colon lavage (IOCL) with primary anastomosis, and the placement of a stent as a temporary measure prior to scheduled surgery. At present, it is not clear whether emergency perioperative lavage or the placement of a stent is the better technique. The hypothesis is that IOCL and primary anastomosis is equal safe or even safer than placement of a stent as a temporary measure prior to scheduled surgery, less length of stay and less cost. OBJECTIVE: To establish which of these two techniques is more efficient in OLCC from the point of view of morbimortality, economic cost, and long-term survival. MATERIAL AND METHODS: Prospective, controlled, randomized study of patients diagnosed with OLCC. Patients were divided into two groups: group 1: stent and deferred surgery; group 2: emergency IOCL. A simple randomization system was used. The estimated sample size required per group was 21 patients. Demographic variables, risk prediction models, postoperative morbimortality, staging, complications due to the placement of stent, surgical time, clinical follow-up, health costs and follow-up of survival were recorded.